Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Novel treatments for urological disorders reported in recent Astellas and Mitsubishi Tanabe patents

Dec. 5, 2007

Nymox reports positive results from clinical study of NX-1207

Dec. 3, 2007

Plethora reports positive preliminary results from phase II study of PSD-503

Dec. 3, 2007

Ardana reports positive preliminary results from phase II study of teverelix LA

Nov. 27, 2007

Cytochroma initiates phase I/II clinical trial of CTAP-101 capsules

Nov. 22, 2007

Recent Novartis patent discloses novel agents for renal failure

Nov. 21, 2007

Quark initiates phase I clinical trial of AKIi-5 for acute renal failure

Nov. 21, 2007

Nymox completes 2-year follow-up study of NX-1207 for benign prostatic hyperplasia

Nov. 20, 2007

Vasohibin beneficial in early diabetic nephropathy model

Nov. 20, 2007

Prolonged renal effects seen with AlbuBNP in dogs

Nov. 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...